Neurology
RSSArticles
-
Pharmacology Update: Lomitapide Capsules (Juxtapid™)
The first inhibitor of the microsomal triglyceride transport protein (MTP) has been approved for the treatment of homozygous familial hypercholesterolemia (HoFH). -
Risk of Bleeding with Warfarin Therapy for Atrial Fibrillation
The authors conclude that in a large cohort of older patients with atrial fibrillation, hemorrhage is common during both the first 30 days and subsequent months of warfarin therapy, and is related to risk factors in the CHADS2 score and also to age. -
Risk of Angioedema with Drug Therapy
The authors concluded that compared to beta-blockers, the risk of angioedema is highest with ACEIs or aliskiren and lowest with ARBs. -
Mammography: Does Early Detection Matter?
Although widespread screening mammography has greatly increased the diagnosis of early breast cancer, it has had only a marginal effect on the diagnosis of late-stage tumors and breast cancer mortality. -
NSAIDs and antihypertensive agents
-
Pharmacology Watch - Full March 2013 Issue in PDF
-
FDA actions
-
Does aspirin cause AMD?
-
Emergency Medicine Reports - Full December 15, 2013 Issue in PDF
-
ECG Review - Mobitz I or Mobitz II AV Block?